Theodore Nowicki is an Oncology physician affiliated with QB3. OpenAlex indexes 304 publications with 2,198 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Ucla Medical Plz Ste 265
Los Angeles, CA 90095
Telephone
310-825-0867Registry record last updated 18 Nov 2019.
Clinical trials
- Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
Sponsor: Jonsson Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Adaptive Biotechnologies CorporationProgram year20222 payments
- Adaptive Biotechnologies CorporationProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- TNF-alpha-"armed" TCR vectors to enhance adoptive cell therapy for solid tumors
University of California Los Angeles
FY2026$647,632R37CA289813 - TNF-alpha-"armed" TCR vectors to enhance adoptive cell therapy for solid tumors
University of California Los Angeles
FY2025$647,632R37CA289813 - Functional epigenomics of transgenic cellular immunotherapies for cancer
University of California Los Angeles
FY2025$181,886K08CA241088
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny
Nature Communications
2025 - Selpercatinib prior to radioactive iodine for pediatric papillary thyroid carcinoma
Journal of Pediatric Endocrinology and Metabolism
2024 - Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis
Cancer Research Communications
2024 - A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer
Cancer Research Communications
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”